+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Iopamidol Injection Market - Global Forecast 2026-2032- Product Image
Iopamidol Injection Market - Global Forecast 2026-2032- Product Image
Sale

Iopamidol Injection Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6129151
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Iopamidol Injection Market is projected to reach USD 1.00 Billion in 2026. It is expected to continue growing at a CAGR of 7.18%, reaching USD 1.52 Billion by 2032.

Iopamidol Injection: Executive Summary and Market Context

Iopamidol injection is an iodinated, nonionic contrast medium used to enhance computed tomography, angiography, and other diagnostic imaging procedures. Its clinical role is shaped by the need for reliable image quality, appropriate concentration selection, safe administration, and adherence to institutional protocols for patients with renal impairment, prior contrast reactions, or other risk factors. Demand is therefore closely connected to diagnostic imaging activity, hospital capacity, radiology workflows, and regulatory requirements rather than to a single procedure or care setting.

Imaging Workflows Are Becoming More Protocol-Driven and Safety-Focused

The landscape is shifting toward standardized contrast-administration protocols, automated injection systems, electronic documentation, and closer coordination between radiology, pharmacy, nursing, and emergency teams. These changes support consistent dosing, reduce avoidable process variation, and improve traceability across outpatient and hospital environments. At the same time, greater attention to renal function assessment, hypersensitivity preparedness, extravasation prevention, and contrast stewardship is influencing product selection and operational practice.

Artificial Intelligence Is Strengthening Contrast-Enabled Diagnostic Workflows

Artificial intelligence is increasingly being applied to image acquisition, protocol selection, reconstruction, triage, and quality assurance. These tools can help identify examinations requiring tailored contrast protocols, improve image quality at lower radiation exposure, and prioritize potentially urgent findings for review. AI does not replace clinical judgment or established safety screening; instead, its cumulative impact depends on validated performance, transparent governance, interoperability with imaging systems, and effective oversight of data quality and bias.

Regional Insights: Uneven Access Meets Common Safety Priorities

North America combines advanced imaging infrastructure with strong emphasis on protocol standardization, medication safety, and electronic workflow integration. Europe is influenced by coordinated regulatory expectations and, within the European Union, cross-border attention to quality and patient protection. Asia-Pacific presents diverse conditions, ranging from highly sophisticated imaging systems in Australia, Japan, and South Korea to rapidly expanding diagnostic capacity elsewhere. Latin America is shaped by uneven access to advanced equipment and specialist services, while Brazil and Mexico remain important reference points for regional care delivery. The Middle East is investing in modern hospitals and diagnostic capability, particularly in Gulf settings, whereas Africa continues to face infrastructure, supply-chain, and specialist-access constraints that make dependable procurement and training especially important.

Group Insights: Policy Alignment and Procurement Shape Adoption

ASEAN markets reflect varied levels of healthcare modernization, reimbursement coverage, and regulatory harmonization, making local implementation and supply reliability central considerations. BRICS members span highly different healthcare systems and imaging capabilities, with procurement conditions and domestic manufacturing policies influencing access. The European Union emphasizes coordinated quality, pharmacovigilance, and clinical governance across member states. G7 countries generally have mature imaging networks and established safety procedures, while GCC systems benefit from concentrated investment in advanced healthcare facilities. NATO members share no single procurement model, but interoperability, hospital readiness, and resilient medical supply chains are relevant across their diverse health systems.

Country Insights: Diverse Clinical Capacity Requires Local Execution

Australia, Canada, France, Germany, Italy, Japan, South Korea, Spain, the United Kingdom, and the United States generally operate mature diagnostic-imaging systems with established contrast-safety protocols, although reimbursement, procurement, and regulatory processes differ. China and India combine substantial imaging demand with regional variation in hospital capability, access, and workflow digitization. Brazil and Mexico show important differences between major urban centers and underserved areas, reinforcing the need for dependable distribution and workforce development. Russia’s imaging environment is shaped by domestic healthcare policy, procurement conditions, and access to specialized equipment. Across all listed countries, local labeling, approved indications, renal-risk procedures, adverse-event reporting, and cold-chain or storage requirements must guide implementation.

Priorities for Leaders: Build Safer, More Resilient Contrast Workflows

Industry leaders should align product positioning and clinical support with evidence-based protocols for patient screening, dosing, administration, and adverse-event management. They should strengthen supply resilience through qualified sourcing, inventory visibility, contingency planning, and clear communication with hospitals and distributors. Investment in interoperable injection, imaging, and electronic medical-record systems can improve traceability and reduce workflow friction. Leaders should also validate AI-enabled tools in representative clinical settings, monitor performance after deployment, and provide practical education for radiologists, technologists, pharmacists, and nursing teams. Local regulatory compliance and equitable access should remain central to expansion decisions.

Research Methodology: Evidence-Based Assessment of Clinical and Operating Context

This executive summary uses a structured secondary-research approach focused on the clinical role, administration practices, safety considerations, imaging workflow developments, and geographic operating environments associated with iopamidol injection. Evidence should be triangulated across regulatory product information, peer-reviewed clinical literature, professional radiology guidance, public health materials, procurement and reimbursement documentation, and credible healthcare-system sources. Regional, group, and country comparisons are qualitative and consider infrastructure, governance, access, digitization, and supply-chain conditions. No market estimates, market sizing, market shares, forecasts, or company-specific claims are used.

Conclusion: Clinical Reliability and Operational Discipline Will Define Progress

Iopamidol injection remains closely linked to the quality and safety of contrast-enhanced diagnostic imaging. Progress will depend on combining appropriate clinical selection with standardized administration, vigilant patient monitoring, dependable supply, and digitally enabled workflows. Regional and country differences require tailored execution, while AI can add value when deployed under rigorous validation and governance. Organizations that integrate safety, resilience, workforce capability, and responsible innovation will be best positioned to support consistent imaging outcomes across diverse healthcare settings.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Iopamidol Injection Market, by Type
7.1. Introduction
7.2. Ionic
7.3. Nonionic
7.3.1. Iso Osmolar
7.3.2. Low Osmolar
8. Iopamidol Injection Market, by Route Of Administration
8.1. Introduction
8.2. Intraarterial
8.3. Intrathecal
8.4. Intravenous
8.4.1. Central Intravenous
8.4.2. Peripheral Intravenous
8.5. Ureteral
9. Iopamidol Injection Market, by Concentration
9.1. Introduction
9.2. High Concentration
9.3. Low Concentration
9.4. Medium Concentration
10. Iopamidol Injection Market, by Application
10.1. Introduction
10.2. Angiography
10.2.1. Cerebral Angiography
10.2.2. Coronary Angiography
10.2.3. Peripheral Angiography
10.3. CT Imaging
10.3.1. Abdomen Imaging
10.3.2. Brain Imaging
10.3.3. Chest Imaging
10.4. Urology
10.4.1. Excretory Urography
10.4.2. Retrograde Urography
11. Iopamidol Injection Market, by End User
11.1. Introduction
11.2. Ambulatory Care Center
11.2.1. Hospital Affiliated Centre
11.2.2. Independent Centre
11.3. Diagnostic Center
11.4. Hospital
11.4.1. Private Hospital
11.4.2. Public Hospital
12. Iopamidol Injection Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Iopamidol Injection Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Iopamidol Injection Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Alvogen, Inc.
16.2. Bayer AG
16.3. Bracco Imaging S.p.A.
16.4. Cipla Limited
16.5. Fresenius Kabi AG
16.6. GE Healthcare
16.7. Guerbet Group
16.8. Hikma Pharmaceuticals PLC
16.9. Jiangsu Hengrui Medicine Co., Ltd.
16.10. Jodas Expoim Pvt. Ltd.
16.11. Lupin Limited
16.12. Pfizer Inc.
16.13. Sagent Pharmaceuticals, Inc.
16.14. Sanochemia Pharmazeutika AG
16.15. Shenzhen Seacrown Pharmaceutical Co., Ltd.
16.16. Sun Pharmaceutical Industries Limited
16.17. Taejoon Pharm Co., Ltd.
16.18. Unijules Life Sciences Ltd.
16.19. Viatris Inc.
16.20. Yangtze River Pharmaceutical Group Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Iopamidol Injection Market, Years Considered for the Study
FIGURE 2. Global Iopamidol Injection Market, Research Design
FIGURE 3. Global Iopamidol Injection Market, Research Framework
FIGURE 4. Global Iopamidol Injection Market, Data Triangulation
FIGURE 5. Global Iopamidol Injection Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Iopamidol Injection Market Size, by Type, 2025 vs 2032 (%)
FIGURE 7. Global Iopamidol Injection Market Size, by Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Iopamidol Injection Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 9. Global Iopamidol Injection Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Iopamidol Injection Market Size, by Concentration, 2025 vs 2032 (%)
FIGURE 11. Global Iopamidol Injection Market Size, by Concentration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Iopamidol Injection Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Iopamidol Injection Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Iopamidol Injection Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Iopamidol Injection Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Iopamidol Injection Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Iopamidol Injection Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Iopamidol Injection Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Iopamidol Injection Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Iopamidol Injection Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Iopamidol Injection Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Iopamidol Injection Market Segmentation & Coverage
TABLE 2. Global Iopamidol Injection Market Size, 2017-2032 (USD Million)
TABLE 3. Global Iopamidol Injection Market Size, by Type, 2017-2032 (USD Million)
TABLE 4. Global Ionic Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Ionic Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Ionic Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Nonionic Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Nonionic Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Nonionic Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Iso Osmolar Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Iso Osmolar Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Iso Osmolar Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Low Osmolar Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Low Osmolar Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Low Osmolar Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Iopamidol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 17. Global Intraarterial Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Intraarterial Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Intraarterial Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Intrathecal Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Intrathecal Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Intrathecal Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Central Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Central Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Central Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Peripheral Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Peripheral Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Peripheral Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Ureteral Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Ureteral Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Ureteral Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Iopamidol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 36. Global High Concentration Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global High Concentration Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global High Concentration Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Low Concentration Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Low Concentration Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Low Concentration Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Medium Concentration Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Medium Concentration Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Medium Concentration Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Iopamidol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 46. Global Angiography Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Angiography Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Angiography Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Cerebral Angiography Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Cerebral Angiography Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Cerebral Angiography Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Coronary Angiography Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Coronary Angiography Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Coronary Angiography Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Peripheral Angiography Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Peripheral Angiography Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Peripheral Angiography Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global CT Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global CT Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global CT Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Abdomen Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Abdomen Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Abdomen Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Brain Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Brain Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Brain Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Chest Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Chest Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Chest Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Urology Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Urology Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Urology Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Excretory Urography Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Excretory Urography Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Excretory Urography Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Retrograde Urography Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Retrograde Urography Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Retrograde Urography Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Iopamidol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 80. Global Ambulatory Care Center Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Ambulatory Care Center Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Ambulatory Care Center Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Hospital Affiliated Centre Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Hospital Affiliated Centre Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Hospital Affiliated Centre Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Independent Centre Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Independent Centre Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Independent Centre Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Diagnostic Center Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Diagnostic Center Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Diagnostic Center Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Private Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Private Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Private Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Public Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Public Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Public Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Iopamidol Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific Iopamidol Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific Iopamidol Injection Market Size, by Type, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific Iopamidol Injection Market Size, by Nonionic, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Iopamidol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Iopamidol Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Iopamidol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific Iopamidol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Iopamidol Injection Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 110. Asia-Pacific Iopamidol Injection Market Size, by CT Imaging, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific Iopamidol Injection Market Size, by Urology, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific Iopamidol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific Iopamidol Injection Market Size, by Ambulatory Care Center, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific Iopamidol Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 115. North America Iopamidol Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. North America Iopamidol Injection Market Size, by Type, 2017-2032 (USD Million)
TABLE 117. North America Iopamidol Injection Market Size, by Nonionic, 2017-2032 (USD Million)
TABLE 118. North America Iopamidol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 119. North America Iopamidol Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 120. North America Iopamidol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 121. North America Iopamidol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 122. North America Iopamidol Injection Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 123. North America Iopamidol Injection Market Size, by CT Imaging, 2017-2032 (USD Million)
TABLE 124. North America Iopamidol Injection Market Size, by Urology, 2017-2032 (USD Million)
TABLE 125. North America Iopamidol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 126. North America Iopamidol Injection Market Size, by Ambulatory Care Center, 2017-2032 (USD Million)
TABLE 127. North America Iopamidol Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 128. Latin America Iopamidol Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Latin America Iopamidol Injection Market Size, by Type, 2017-2032 (USD Million)
TABLE 130. Latin America Iopamidol Injection Market Size, by Nonionic, 2017-2032 (USD Million)
TABLE 131. Latin America Iopamidol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 132. Latin America Iopamidol Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 133. Latin America Iopamidol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 134. Latin America Iopamidol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 135. Latin America Iopamidol Injection Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 136. Latin America Iopamidol Injection Market Size, by CT Imaging, 2017-2032 (USD Million)
TABLE 137. Latin America Iopamidol Injection Market Size, by Urology, 2017-2032 (USD Million)
TABLE 138. Latin America Iopamidol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. Latin America Iopamidol Injection Market Size, by Ambulatory Care Center, 2017-2032 (USD Million)
TABLE 140. Latin America Iopamidol Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 141. Europe Iopamidol Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Europe Iopamidol Injection Market Size, by Type, 2017-2032 (USD Million)
TABLE 143. Europe Iopamidol Injection Market Size, by Nonionic, 2017-2032 (USD Million)
TABLE 144. Europe Iopamidol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 145. Europe Iopamidol Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 146. Europe Iopamidol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 147. Europe Iopamidol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 148. Europe Iopamidol Injection Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 149. Europe Iopamidol Injection Market Size, by CT Imaging, 2017-2032 (USD Million)
TABLE 150. Europe Iopamidol Injection Market Size, by Urology, 2017-2032 (USD Million)
TABLE 151. Europe Iopamidol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. Europe Iopamidol Injection Market Size, by Ambulatory Care Center, 2017-2032 (USD Million)
TABLE 153. Europe Iopamidol Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 154. Middle East Iopamidol Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 155. Middle East Iopamidol Injection Market Size, by Type, 2017-2032 (USD Million)
TABLE 156. Middle East Iopamidol Injection Market Size, by Nonionic, 2017-2032 (USD Million)
TABLE 157. Middle East Iopamidol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 158. Middle East Iopamidol Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 159. Middle East Iopamidol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 160. Middle East Iopamidol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 161. Middle East Iopamidol Injection Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 162. Middle East Iopamidol Injection Market Size, by CT Imaging, 2017-2032 (USD Million)
TABLE 163. Middle East Iopamidol Injection Market Size, by Urology, 2017-2032 (USD Million)
TABLE 164. Middle East Iopamidol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. Middle East Iopamidol Injection Market Size, by Ambulatory Care Center, 2017-2032 (USD Million)
TABLE 166. Middle East Iopamidol Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 167. Africa Iopamidol Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 168. Africa Iopamidol Injection Market Size, by Type, 2017-2032 (USD Million)
TABLE 169. Africa Iopamidol Injection Market Size, by Nonionic, 2017-2032 (USD Million)
TABLE 170. Africa Iopamidol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 171. Africa Iopamidol Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 172. Africa Iopamidol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 173. Africa Iopamidol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 174. Africa Iopamidol Injection Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 175. Africa Iopamidol Injection Market Size, by CT Imaging, 2017-2032 (USD Million)
TABLE 176. Africa Iopamidol Injection Market Size, by Urology, 2017-2032 (USD Million)
TABLE 177. Africa Iopamidol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. Africa Iopamidol Injection Market Size, by Ambulatory Care Center, 2017-2032 (USD Million)
TABLE 179. Africa Iopamidol Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 180. Global Iopamidol Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 181. ASEAN Iopamidol Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 182. ASEAN Iopamidol Injection Market Size, by Type, 2017-2032 (USD Million)
TABLE 183. ASEAN Iopamidol Injection Market Size, by Nonionic, 2017-2032 (USD Million)
TABLE 184. ASEAN Iopamidol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 185. ASEAN Iopamidol Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 186. ASEAN Iopamidol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 187. ASEAN Iopamidol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 188. ASEAN Iopamidol Injection Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 189. ASEAN Iopamidol Injection Market Size, by CT Imaging, 2017-2032 (USD Million)
TABLE 190. ASEAN Iopamidol Injection Market Size, by Urology, 2017-2032 (USD Million)
TABLE 191. ASEAN Iopamidol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 192. ASEAN Iopamidol Injection Market Size, by Ambulatory Care Center, 2017-2032 (USD Million)
TABLE 193. ASEAN Iopamidol Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 194. GCC Iopamidol Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 195. GCC Iopamidol Injection Market Size, by Type, 2017-2032 (USD Million)
TABLE 196. GCC Iopamidol Injection Market Size, by Nonionic, 2017-2032 (USD Million)
TABLE 197. GCC Iopamidol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 198. GCC Iopamidol Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 199. GCC Iopamidol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 200. GCC Iopamidol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 201. GCC Iopamidol Injection Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 202. GCC Iopamidol Injection Market Size, by CT Imaging, 2017-2032 (USD Million)
TABLE 203. GCC Iopamidol Injection Market Size, by Urology, 2017-2032 (USD Million)
TABLE 204. GCC Iopamidol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. GCC Iopamidol Injection Market Size, by Ambulatory Care Center, 2017-2032 (USD Million)
TABLE 206. GCC Iopamidol Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 207. European Union Iopamidol Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 208. European Union Iopamidol Injection Market Size, by Type, 2017-2032 (USD Million)
TABLE 209. European Union Iopamidol Injection Market Size, by Nonionic, 2017-2032 (USD Million)
TABLE 210. European Union Iopamidol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 211. European Union Iopamidol Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 212. European Union Iopamidol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 213. European Union Iopamidol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 214. European Union Iopamidol Injection Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 215. European Union Iopamidol Injection Market Size, by CT Imaging, 2017-2032 (USD Million)
TABLE 216. European Union Iopamidol Injection Market Size, by Urology, 2017-2032 (USD Million)
TABLE 217. European Union Iopamidol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 218. European Union Iopamidol Injection Market Size, by Ambulatory Care Center, 2017-2032 (USD Million)
TABLE 219. European Union Iopamidol Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 220. BRICS Iopamidol Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 221. BRICS Iopamidol Injection Market Size, by Type, 2017-2032 (USD Million)
TABLE 222. BRICS Iopamidol Injection Market Size, by Nonionic, 2017-2032 (USD Million)
TABLE 223. BRICS Iopamidol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 224. BRICS Iopamidol Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 225. BRICS Iopamidol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 226. BRICS Iopamidol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 227. BRICS Iopamidol Injection Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 228. BRICS Iopamidol Injection Market Size, by CT Imaging, 2017-2032 (USD Million)
TABLE 229. BRICS Iopamidol Injection Market Size, by Urology, 2017-2032 (USD Million)
TABLE 230. BRICS Iopamidol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 231. BRICS Iopamidol Injection Market Size, by Ambulatory Care Center, 2017-2032 (USD Million)
TABLE 232. BRICS Iopamidol Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 233. G7 Iopamidol Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 234. G7 Iopamidol Injection Market Size, by Type, 2017-2032 (USD Million)
TABLE 235. G7 Iopamidol Injection Market Size, by Nonionic, 2017-2032 (USD Million)
TABLE 236. G7 Iopamidol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 237. G7 Iopamidol Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 238. G7 Iopamidol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 239. G7 Iopamidol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 240. G7 Iopamidol Injection Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 241. G7 Iopamidol Injection Market Size, by CT Imaging, 2017-2032 (USD Million)
TABLE 242. G7 Iopamidol Injection Market Size, by Urology, 2017-2032 (USD Million)
TABLE 243. G7 Iopamidol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 244. G7 Iopamidol Injection Market Size, by Ambulatory Care Center, 2017-2032 (USD Million)
TABLE 245. G7 Iopamidol Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 246. NATO Iopamidol Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 247. NATO Iopamidol Injection Market Size, by Type, 2017-2032 (USD Million)
TABLE 248. NATO Iopamidol Injection Market Size, by Nonionic, 2017-2032 (USD Million)
TABLE 249. NATO Iopamidol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 250. NATO Iopamidol Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 251. NATO Iopamidol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 252. NATO Iopamidol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 253. NATO Iopamidol Injection Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 254. NATO Iopamidol Injection Market Size, by CT Imaging, 2017-2032 (USD Million)
TABLE 255. NATO Iopamidol Injection Market Size, by Urology, 2017-2032 (USD Million)
TABLE 256. NATO Iopamidol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 257. NATO Iopamidol Injection Market Size, by Ambulatory Care Center, 2017-2032 (USD Million)
TABLE 258. NATO Iopamidol Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 259. Global Iopamidol Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 260. United States Iopamidol Injection Market Size, 2017-2032 (USD Million)
TABLE 261. United States Iopamidol Injection Market Size, by Type, 2017-2032 (USD Million)
TABLE 262. United States Iopamidol Injection Market Size, by Nonionic, 2017-2032 (USD Million)
TABLE 263. United States Iopamidol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 264. United States Iopamidol Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 265. United States Iopamidol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 266. United States Iopamidol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 267. United States Iopamidol Injection Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 268. United States Iopamidol Injection Market Size, by CT Imaging, 2017-2032 (USD Million)
TABLE 269. United States Iopamidol Injection Market Size, by Urology, 2017-2032 (USD Million)
TABLE 270. United States Iopamidol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 271. United States Iopamidol Injection Market Size, by Ambulatory Care Center, 2017-2032 (USD Million)
TABLE 272. United States Iopamidol Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 273. Canada Iopamidol Injection Market Size, 2017-2032 (USD Million)
TABLE 274. Canada Iopamidol Injection Market Size, by Type, 2017-2032 (USD Million)
TABLE 275. Canada Iopamidol Injection Market Size, by Nonionic, 2017-2032 (USD Million)
TABLE 276. Canada Iopamidol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 277. Canada Iopamidol Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 278. Canada Iopamidol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 279. Canada Iopamidol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 280. Canada Iopamidol Injection Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 281. Canada Iopamidol Injection Market Size, by CT Imaging, 2017-2032 (USD Million)
TABLE 282. Canada Iopamidol Injection Market Size, by Urology, 2017-2032 (USD Million)
TABLE 283. Canada Iopamidol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 284. Canada Iopamidol Injection Market Size, by Ambulatory Care Center, 2017-2032 (USD Million)
TABLE 285. Canada Iopamidol Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 286. Mexico Iopamidol Injection Market Size, 2017-2032 (USD Million)
TABLE 287. Mexico Iopamidol Injection Market Size, by Type, 2017-2032 (USD Million)
TABLE 288. Mexico Iopamidol Injection Market Size, by Nonionic, 2017-2032 (USD Million)
TABLE 289. Mexico Iopamidol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 290. Mexico Iopamidol Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 291. Mexico Iopamidol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 292. Mexico Iopamidol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 293. Mexico Iopamidol Injection Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 294. Mexico Iopamidol Injection Market Size, by CT Imaging, 2017-2032 (USD Million)
TABLE 295. Mexico Iopamidol Injection Market Size, by Urology, 2017-2032 (USD Million)
TABLE 296. Mexico Iopamidol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 297. Mexico Iopamidol Injection Market Size, by Ambulatory Care Center, 2017-2032 (USD Million)
TABLE 298. Mexico Iopamidol Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 299. Brazil Iopamidol Injection Market Size, 2017-2032 (USD Million)
TABLE 300. Brazil Iopamidol Injection Market Size, by Type, 2017-2032 (USD Million)
TABLE 301. Brazil Iopamidol Injection Market Size, by Nonionic, 2017-2032 (USD Million)
TABLE 302. Brazil Iopamidol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 303. Brazil Iopamidol Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 304. Brazil Iopamidol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 305. Brazil Iopamidol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 306. Brazil Iopamidol Injection Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 307. Brazil Iopamidol Injection Market Size, by CT Imaging, 2017-2032 (USD Million)
TABLE 308. Brazil Iopamidol Injection Market Size, by Urology, 2017-2032 (USD Million)
TABLE 309. Brazil Iopamidol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 310. Brazil Iopamidol Injection Market Size, by Ambulatory Care Center, 2017-2032 (USD Million)
TABLE 311. Brazil Iopamidol Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 312. United Kingdom Iopamidol Injection Market Size, 2017-2032 (USD Million)
TABLE 313. United Kingdom Iopamidol Injection Market Size, by Type, 2017-2032 (USD Million)
TABLE 314. United Kingdom Iopamidol Injection Market Size, by Nonionic, 2017-2032 (USD Million)
TABLE 315. United Kingdom Iopamidol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 316. United Kingdom Iopamidol Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 317. United Kingdom Iopamidol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 318. United Kingdom Iopamidol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 319. United Kingdom Iopamidol Injection Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 320. United Kingdom Iopamidol Injection Market Size, by CT Imaging, 2017-2032 (USD Million)
TABLE 321. United Kingdom Iopamidol Injection Market Size, by Urology, 2017-2032 (USD Million)
TABLE 322. United Kingdom Iopamidol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 323. United Kingdom Iopamidol Injection Market Size, by Ambulatory Care Center, 2017-2032 (USD Million)
TABLE 324. United Kingdom Iopamidol Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 325. Germany Iopamidol Injection Market Size, 2017-2032 (USD Million)
TABLE 326. Germany Iopamidol Injection Market Size, by Type, 2017-2032 (USD Million)
TABLE 327. Germany Iopamidol Injection Market Size, by Nonionic, 2017-2032 (USD Million)
TABLE 328. Germany Iopamidol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 329. Germany Iopamidol Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 330. Germany Iopamidol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 331. Germany Iopamidol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 332. Germany Iopamidol Injection Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 333. Germany Iopamidol Injection Market Size, by CT Imaging, 2017-2032 (USD Million)
TABLE 334. Germany Iopamidol Injection Market Size, by Urology, 2017-2032 (USD Million)
TABLE 335. Germany Iopamidol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 336. Germany Iopamidol Injection Market Size, by Ambulatory Care Center, 2017-2032 (USD Million)
TABLE 337. Germany Iopamidol Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 338. France Iopamidol Injection Market Size, 2017-2032 (USD Million)
TABLE 339. France Iopamidol Injection Market Size, by Type, 2017-2032 (USD Million)
TABLE 340. France Iopamidol Injection Market Size, by Nonionic, 2017-2032 (USD Million)
TABLE 341. France Iopamidol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 342. France Iopamidol Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 343. France Iopamidol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 344. France Iopamidol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 345. France Iopamidol Injection Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 346. France Iopamidol Injection Market Size, by CT Imaging, 2017-2032 (USD Million)
TABLE 347. France Iopamidol Injection Market Size, by Urology, 2017-2032 (USD Million)
TABLE 348. France Iopamidol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 349. France Iopamidol Injection Market Size, by Ambulatory Care Center, 2017-2032 (USD Million)
TABLE 350. France Iopamidol Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 351. Russia Iopamidol Injection Market Size, 2017-2032 (USD Million)
TABLE 352. Russia Iopamidol Injection Market Size, by Type, 2017-2032 (USD Million)
TABLE 353. Russia Iopamidol Injection Market Size, by Nonionic, 2017-2032 (USD Million)
TABLE 354. Russia Iopamidol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 355. Russia Iopamidol Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 356. Russia Iopamidol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 357. Russia Iopamidol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 358. Russia Iopamidol Injection Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 359. Russia Iopamidol Injection Market Size, by CT Imaging, 2017-2032 (USD Million)
TABLE 360. Russia Iopamidol Injection Market Size, by Urology, 2017-2032 (USD Million)
TABLE 361. Russia Iopamidol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 362. Russia Iopamidol Injection Market Size, by Ambulatory Care Center, 2017-2032 (USD Million)
TABLE 363. Russia Iopamidol Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 364. Italy Iopamidol Injection Market Size, 2017-2032 (USD Million)
TABLE 365. Italy Iopamidol Injection Market Size, by Type, 2017-2032 (USD Million)
TABLE 366. Italy Iopamidol Injection Market Size, by Nonionic, 2017-2032 (USD Million)
TABLE 367. Italy Iopamidol Injection Market Size, by Route Of Administration, 2017-2032 (USD Millio

Companies Mentioned

  • Alvogen, Inc.
  • Bayer AG
  • Bracco Imaging S.p.A.
  • Cipla Limited
  • Fresenius Kabi AG
  • GE Healthcare
  • Guerbet Group
  • Hikma Pharmaceuticals PLC
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Jodas Expoim Pvt. Ltd.
  • Lupin Limited
  • Pfizer Inc.
  • Sagent Pharmaceuticals, Inc.
  • Sanochemia Pharmazeutika AG
  • Shenzhen Seacrown Pharmaceutical Co., Ltd.
  • Sun Pharmaceutical Industries Limited
  • Taejoon Pharm Co., Ltd.
  • Unijules Life Sciences Ltd.
  • Viatris Inc.
  • Yangtze River Pharmaceutical Group Ltd.

Related Topics

Related Reports

Contrast Injection Lines Market Report 2026 - Product Image

Contrast Injection Lines Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Carbetocin for Injection Market - Global Forecast 2026-2032 - Product Image

Carbetocin for Injection Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Colistimethate Sodium for Injection Market - Global Forecast 2026-2032 - Product Image

Colistimethate Sodium for Injection Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Self-Injections Market Report 2026 - Product Image

Self-Injections Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Botulinum Toxin Injection Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type - Product Image

Botulinum Toxin Injection Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 118 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.